| __timestamp | Catalent, Inc. | HUTCHMED (China) Limited |
|---|---|---|
| Wednesday, January 1, 2014 | 598600000 | 19764000 |
| Thursday, January 1, 2015 | 615300000 | 67426000 |
| Friday, January 1, 2016 | 587600000 | 59752000 |
| Sunday, January 1, 2017 | 654600000 | 65383000 |
| Monday, January 1, 2018 | 752600000 | 70165000 |
| Tuesday, January 1, 2019 | 805100000 | 44738000 |
| Wednesday, January 1, 2020 | 983300000 | 39457000 |
| Friday, January 1, 2021 | 1352000000 | 97894000 |
| Saturday, January 1, 2022 | 1640000000 | 115306000 |
| Sunday, January 1, 2023 | 1060000000 | 453552000 |
| Monday, January 1, 2024 | 953000000 |
In pursuit of knowledge
In the ever-evolving landscape of the pharmaceutical industry, Catalent, Inc. and HUTCHMED (China) Limited have showcased contrasting trajectories in their gross profit margins over the past decade. Catalent, Inc., a leader in drug development and delivery, has seen its gross profit soar by approximately 175% from 2014 to 2023, peaking in 2022. This growth underscores Catalent's strategic expansions and innovations in drug delivery technologies.
Conversely, HUTCHMED (China) Limited, a biopharmaceutical company focused on oncology and immunology, has experienced a more volatile journey. Despite a significant 1300% increase in gross profit from 2014 to 2023, the company faced fluctuations, with a notable peak in 2023. This reflects the challenges and breakthroughs in the competitive biopharmaceutical sector. The data for 2024 remains incomplete, leaving room for speculation on future trends.
Gross Profit Analysis: Comparing Pfizer Inc. and HUTCHMED (China) Limited
Who Generates Higher Gross Profit? Takeda Pharmaceutical Company Limited or Catalent, Inc.
Genmab A/S and HUTCHMED (China) Limited: A Detailed Gross Profit Analysis
Dr. Reddy's Laboratories Limited vs HUTCHMED (China) Limited: A Gross Profit Performance Breakdown
Who Generates Higher Gross Profit? Catalent, Inc. or Grifols, S.A.
Gross Profit Analysis: Comparing Catalent, Inc. and Taro Pharmaceutical Industries Ltd.
Ascendis Pharma A/S and HUTCHMED (China) Limited: A Detailed Gross Profit Analysis
Gross Profit Trends Compared: Alkermes plc vs HUTCHMED (China) Limited
Key Insights on Gross Profit: Amneal Pharmaceuticals, Inc. vs HUTCHMED (China) Limited
Gross Profit Comparison: Vericel Corporation and HUTCHMED (China) Limited Trends
Who Generates Higher Gross Profit? HUTCHMED (China) Limited or Ligand Pharmaceuticals Incorporated
Gross Profit Analysis: Comparing HUTCHMED (China) Limited and MiMedx Group, Inc.